Natriuretic peptides: putting the evidence into practice.
With advances in cardiovascular medicine, people are living longer with cardiovascular disease. There is an increased incidence and prevalence of heart failure. Misdiagnosis of heart failure, particularly in the early stages, is not uncommon. Natriuretic peptides (BNP and NT-proBNP) have been established to be of additional value to the clinical examination in heart failure diagnosis and management. As frontline caregivers for heart failure patients, nurses should be aware of the clinical use of these peptides either as a complementary diagnostic test for heart failure or as a possible therapeutic modality.
Andrade
Ada
A
St. Michael's Hospital, Toronto, Ontario.
Sharar
Haytham
H
D015415:Biomarkers / Q000097:blood; D002170:Canada; D006333:Heart Failure / Q000175:diagnosis*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain